| Bortezomib 1 mg powder for solution for injection PA23142/012/001 |
Bortezomib |
Aspire Pharma (Malta) Limited |
Not marketed |
| Bortezomib 2.5 mg powder for solution for injection PA23142/012/003 |
Bortezomib |
Aspire Pharma (Malta) Limited |
Not marketed |
| Bortezomib 3.5 mg powder for solution for injection PA23142/012/002 |
Bortezomib |
Aspire Pharma (Malta) Limited |
Not marketed |
| Buprenorphine 2 mg Sublingual Tablets PA23142/003/001 |
Buprenorphine hydrochloride |
Aspire Pharma (Malta) Limited |
Not marketed |
| Buprenorphine 8 mg Sublingual Tablets PA23142/003/002 |
Buprenorphine hydrochloride |
Aspire Pharma (Malta) Limited |
Not marketed |
| Clindamycin + Benzoyl Peroxide 10 mg/g + 50 mg/g gel PA23142/015/001 |
Clindamycin, Anhydrous Benzoyl Peroxide |
Aspire Pharma (Malta) Limited |
Not marketed |
| Clorom XL 500 mg Prolonged-Release Tablets PA23142/006/001 |
Clarithromycin |
Aspire Pharma (Malta) Limited |
Marketed |
| Ethambutol Hydrochloride 100mg film-coated tablets PA23142/004/001 |
Ethambutol hydrochloride |
Aspire Pharma (Malta) Limited |
Not marketed |
| Ethambutol Hydrochloride 400mg film-coated tablets PA23142/004/002 |
Ethambutol hydrochloride |
Aspire Pharma (Malta) Limited |
Not marketed |
| Eyreida 0.3 mg/ml eye drops, solution PA23142/014/001 |
Bimatoprost |
Aspire Pharma (Malta) Limited |
Not marketed |
| Eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution PA23142/013/001 |
Bimatoprost, Timolol Maleate |
Aspire Pharma (Malta) Limited |
Not marketed |
| Leflunomide 10 mg film-coated tablets PA23142/009/001 |
Leflunomide |
Aspire Pharma (Malta) Limited |
Not marketed |
| Leflunomide 20mg film-coated tablets PA23142/009/002 |
Leflunomide |
Aspire Pharma (Malta) Limited |
Not marketed |
| Lorazepam 1mg tablets PA23142/007/001 |
Lorazepam |
Aspire Pharma (Malta) Limited |
Not marketed |
| Lorazepam 2.5 mg tablets PA23142/007/002 |
Lorazepam |
Aspire Pharma (Malta) Limited |
Not marketed |
| Methotrexate 10 mg tablets PA23142/005/001 |
Methotrexate |
Aspire Pharma (Malta) Limited |
Not marketed |
| Methotrexate 2.5mg tablets PA23142/005/002 |
Methotrexate |
Aspire Pharma (Malta) Limited |
Not marketed |
| Midodrine Hydrochloride Aspire 2.5 mg tablets PA23142/008/001 |
Midodrine hydrochloride |
Aspire Pharma (Malta) Limited |
Not marketed |
| Midodrine Hydrochloride Aspire 5 mg tablets PA23142/008/002 |
Midodrine hydrochloride |
Aspire Pharma (Malta) Limited |
Not marketed |
| Modrasone Cream 0.05% w/w PA23142/011/001 |
Alclometasone dipropionate |
Aspire Pharma (Malta) Limited |
Not marketed |
| Modrasone Ointment 0.05% w/w PA23142/011/002 |
Alclometasone dipropionate |
Aspire Pharma (Malta) Limited |
Not marketed |
| Vensir XL 150 mg prolonged-release hard capsules PA23142/002/002 |
Venlafaxine |
Aspire Pharma (Malta) Limited |
Not marketed |
| Vensir XL 75 mg prolonged-release hard capsules PA23142/002/001 |
Venlafaxine hydrochloride |
Aspire Pharma (Malta) Limited |
Not marketed |
| Zedbac 500 mg powder for concentrate for solution for infusion PA23142/010/001 |
Azithromycin dihydrate |
Aspire Pharma (Malta) Limited |
Not marketed |
| Zindaclin 1% Gel PA23142/016/001 |
CLINDAMYCIN PHOSPHATE |
Aspire Pharma (Malta) Limited |
Not marketed |